Novel compounds of the formula I
in which
-Y-Z-, R1,R2,R3,R4,R5 and X have the meaning indicated in Patent Claim 1, and their salts
show endothelin receptor-antagonistic properties.
式 I 的新型化合物
其中
-Y-Z-、R1,R2,R3,R4,R5 和 X 具有专利权利要求 1 中所示的含义,以及它们的盐类
具有内皮素受体拮抗特性。
Sharma,K.S. et al., Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 1977, vol. 15B, p. 968 - 969
作者:Sharma,K.S. et al.
DOI:——
日期:——
Sharma,K.S. et al., Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 1976, vol. 14, p. 1001 - 1003
作者:Sharma,K.S. et al.
DOI:——
日期:——
SHARMA K. S.; SINGH VIJENDER; CHUGH T. D.; WALIA S. K., INDIAN J. CHEM., 1977, B 15, NO 10, 968-969
作者:SHARMA K. S.、 SINGH VIJENDER、 CHUGH T. D.、 WALIA S. K.